With rare exceptions, biotechnology and pharmaceutical companies validate their business plans through clinical trials, results from which are often presented and dissected at medical conferences throughout the year. These are the forums where executives get to showcase the “proof of concept" they so frequently talk about.
Some meetings tend to spotlight the early human research that first indicates a new treatment’s potential. Others are for the late-stage study findings that can pave the way toward regulatory approval.
Below, BioPharma Dive has collected schedules for the key medical meetings planned for the rest of 2025.
Top medical and industry meetings in 2025
European Society of Cardiology Annual Congress
Aug. 29 - Sept. 1, 2025
Madrid
In 2025, ESC will be held together with the World Congress of Cardiology, a co-hosting that last occurred in 2019. The conference organizers say the collaboration will highlight how heart disease remains the world’s leading cause of death.
European Society of Medical Oncology Congress
Oct. 17 - 21, 2025
Berlin
ESMO is Europe’s answer to the American Society of Clinical Oncology’s annual meeting and just as often features standard-shifting cancer research. While immunotherapy remains an active area of exploration for drugmakers, increasingly other treatment types like antibody-drug conjugates and radiopharmaceuticals have been featured at oncology conferences.
The Liver Meeting
Nov. 7 - 11, 2025
Washington, D.C.
Thousands of hepatology professionals gather each year at the American Association for the Study of Liver Diseases’ annual meeting.
American Heart Association Scientific Sessions
Nov. 8 - 10, 2025
New Orleans
AHA is always a major forum for the latest research on medicines to treat diseases of the heart.
18th Clinical Trials on Alzheimer's Disease
Dec. 1 - 4, 2024
San Diego
Focused on medicines for Alzheimer’s disease, CTAD hosts researchers and experts in the field to discuss new treatment approaches for the neurological condition.
American Society of Hematology Annual Meeting
Dec. 6 - 9, 2025
Orlando
This meeting regularly features compelling new research on treatments for diseases of the blood, from cancers to non-malignant disorders like sickle cell and beta thalassemia.
